OBJECTIVES: The objective of this prospective, single-site, 2-year dietary intervention study was to evaluate the effects of moderate weight reduction and subsequent partial weight regain on cardiovascular structure and function. BACKGROUND: Obesity is associated with adverse cardiac and vascular structural and functional alterations. METHODS:Sixty obese subjects (age 46 + or - 10 years, body mass index 37 + or - 3 kg/m(2)) were evaluated during their participation in a weight loss study. Cardiac and vascular ultrasound studies were performed at baseline and at 3, 6, 12, and 24 months after start of intervention. RESULTS:Forty-seven subjects (78%) completed the entire 2-year follow-up. Average weight loss was 7.3 + or - 4.0%, 9.2 + or - 5.6%, 7.8 + or - 6.6%, and 3.8 + or - 7.9% at 3, 6, 12, and 24 months, respectively. Age- and sex-adjusted mixed linear models revealed that the follow-up time was significantly associated with decreases in weight (p < 0.0001), left ventricular (LV) mass (p = 0.001), and carotid intima-media thickness (p < 0.0001); there was also significant improvement in LV diastolic (p < or = 0.0001) and systolic (p = 0.001) function. Partial weight regain diminished the maximal observed beneficial effects of weight loss, however cardiovascular parameters measured at 2 years still showed a net benefit compared with baseline. CONCLUSIONS: Diet-induced moderate weight loss in obese subjects is associated with beneficial changes in cardiovascular structure and function. Subsequent weight regain is associated with partial loss of these beneficial effects. (The Safety and Effectiveness of Low and High Carbohydrate Diets; NCT00079547).
RCT Entities:
OBJECTIVES: The objective of this prospective, single-site, 2-year dietary intervention study was to evaluate the effects of moderate weight reduction and subsequent partial weight regain on cardiovascular structure and function. BACKGROUND:Obesity is associated with adverse cardiac and vascular structural and functional alterations. METHODS: Sixty obese subjects (age 46 + or - 10 years, body mass index 37 + or - 3 kg/m(2)) were evaluated during their participation in a weight loss study. Cardiac and vascular ultrasound studies were performed at baseline and at 3, 6, 12, and 24 months after start of intervention. RESULTS: Forty-seven subjects (78%) completed the entire 2-year follow-up. Average weight loss was 7.3 + or - 4.0%, 9.2 + or - 5.6%, 7.8 + or - 6.6%, and 3.8 + or - 7.9% at 3, 6, 12, and 24 months, respectively. Age- and sex-adjusted mixed linear models revealed that the follow-up time was significantly associated with decreases in weight (p < 0.0001), left ventricular (LV) mass (p = 0.001), and carotid intima-media thickness (p < 0.0001); there was also significant improvement in LV diastolic (p < or = 0.0001) and systolic (p = 0.001) function. Partial weight regain diminished the maximal observed beneficial effects of weight loss, however cardiovascular parameters measured at 2 years still showed a net benefit compared with baseline. CONCLUSIONS: Diet-induced moderate weight loss in obese subjects is associated with beneficial changes in cardiovascular structure and function. Subsequent weight regain is associated with partial loss of these beneficial effects. (The Safety and Effectiveness of Low and High Carbohydrate Diets; NCT00079547).
Authors: G de Simone; S R Daniels; R B Devereux; R A Meyer; M J Roman; O de Divitiis; M H Alderman Journal: J Am Coll Cardiol Date: 1992-11-01 Impact factor: 24.094
Authors: A Ganau; R B Devereux; M J Roman; G de Simone; T G Pickering; P S Saba; P Vargiu; I Simongini; J H Laragh Journal: J Am Coll Cardiol Date: 1992-06 Impact factor: 24.094
Authors: Linda R Peterson; Pilar Herrero; Kenneth B Schechtman; Susan B Racette; Alan D Waggoner; Zulia Kisrieva-Ware; Carmen Dence; Samuel Klein; JoAnn Marsala; Timothy Meyer; Robert J Gropler Journal: Circulation Date: 2004-05-03 Impact factor: 29.690
Authors: D W Sohn; I H Chai; D J Lee; H C Kim; H S Kim; B H Oh; M M Lee; Y B Park; Y S Choi; J D Seo; Y W Lee Journal: J Am Coll Cardiol Date: 1997-08 Impact factor: 24.094
Authors: Hideo Makimura; Meghan N Feldpausch; Alison M Rope; Linda C Hemphill; Martin Torriani; Hang Lee; Steven K Grinspoon Journal: J Clin Endocrinol Metab Date: 2012-09-26 Impact factor: 5.958
Authors: Jacqueline T Jonker; Marieke Snel; Sebastiaan Hammer; Ingrid M Jazet; Rutger W van der Meer; Hanno Pijl; A Edo Meinders; Albert de Roos; Johannes W A Smit; Johannes A Romijn; Hildo J Lamb Journal: Int J Cardiovasc Imaging Date: 2013-10-16 Impact factor: 2.357
Authors: C Huie Lin; Suraj Kurup; Pilar Herrero; Kenneth B Schechtman; J Christopher Eagon; Samuel Klein; Víctor G Dávila-Román; Richard I Stein; Gerald W Dorn; Robert J Gropler; Alan D Waggoner; Linda R Peterson Journal: Obesity (Silver Spring) Date: 2011-07-07 Impact factor: 5.002
Authors: G Lambert; Marcelo Miranda de Oliveira Lima; A C Felici; J C Pareja; A C J Vasques; F S Novaes; S Rodovalho; F F P Hirsch; J R Matos-Souza; Élinton A Chaim; B Geloneze Journal: Obes Surg Date: 2018-01 Impact factor: 4.129
Authors: Lisa de las Fuentes; Giovanni de Simone; Donna K Arnett; Víctor G Dávila-Román Journal: Endocr Metab Immune Disord Drug Targets Date: 2010-06 Impact factor: 2.895
Authors: Hailey Hayes; Jacob Patz; John Corbett; Muhammad Z Afzal; Jennifer Strande; Tammy L Kindel Journal: Surg Obes Relat Dis Date: 2019-03-23 Impact factor: 4.734
Authors: Karen A Frankwich; Jeremy Egnatios; Mandy L Kenyon; Thomas R Rutledge; Patricia S Liao; Samir Gupta; Karen L Herbst; Amir Zarrinpar Journal: Clin Gastroenterol Hepatol Date: 2015-03-10 Impact factor: 11.382